These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28209652)

  • 1. Progressive spinal cord atrophy in manifest and premanifest Huntington's disease.
    Wilhelms W; Bellenberg B; Köster O; Weiler F; Hoffmann R; Gold R; Saft C; Lukas C
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):614-616. PubMed ID: 28209652
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.
    Harrington DL; Long JD; Durgerian S; Mourany L; Koenig K; Bonner-Jackson A; Paulsen JS; ; Rao SM
    Mov Disord; 2016 Nov; 31(11):1664-1675. PubMed ID: 27620011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease.
    Sarappa C; Salvatore E; Filla A; Cocozza S; Russo CV; Saccà F; Brunetti A; De Michele G; Quarantelli M
    Brain Imaging Behav; 2017 Oct; 11(5):1459-1469. PubMed ID: 27734308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.
    Sampedro F; Martínez-Horta S; Perez-Perez J; Horta-Barba A; Lopez-Mora DA; Camacho V; Fernández-León A; Gomez-Anson B; Carrió I; Kulisevsky J
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1111-1116. PubMed ID: 30627816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI-Application in Premanifest Huntington's Disease.
    Wu D; Faria AV; Younes L; Ross CA; Mori S; Miller MI
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corpus callosal atrophy in premanifest and early Huntington's disease.
    Crawford HE; Hobbs NZ; Keogh R; Langbehn DR; Frost C; Johnson H; Landwehrmeyer B; Reilmann R; Craufurd D; Stout JC; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Scahill RI;
    J Huntingtons Dis; 2013; 2(4):517-26. PubMed ID: 25062736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postural limits of stability in premanifest and manifest Huntington's disease.
    Medina LD; Pirogovsky E; Salomonczyk D; Goldstein J; Panzera R; Gluhm S; Simmons R; Corey-Bloom J; Gilbert PE
    J Huntingtons Dis; 2013; 2(2):177-84. PubMed ID: 25063514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Frost C; MacManus DG; Barker RA; Fox NC; Tabrizi SJ
    Mov Disord; 2009 Apr; 24(6):932-6. PubMed ID: 19243073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
    Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
    Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Magnetic Resonance Imaging in Huntington's Disease.
    Gregory S; Scahill RI
    Int Rev Neurobiol; 2018; 142():381-408. PubMed ID: 30409260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.
    Hobbs NZ; Pedrick AV; Say MJ; Frost C; Dar Santos R; Coleman A; Sturrock A; Craufurd D; Stout JC; Leavitt BR; Barnes J; Tabrizi SJ; Scahill RI
    Mov Disord; 2011 Aug; 26(9):1684-90. PubMed ID: 21557312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.